List of Tables
Table 1. Global Microbial Antibacterial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Microbial Antibacterial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Microbial Antibacterial Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Microbial Antibacterial Drugs Sales (Kilotons) of Key Manufacturers (2020-2025)
Table 5. Global Microbial Antibacterial Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Microbial Antibacterial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Microbial Antibacterial Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Microbial Antibacterial Drugs Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Microbial Antibacterial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Microbial Antibacterial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Microbial Antibacterial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Microbial Antibacterial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Microbial Antibacterial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Antibacterial Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Microbial Antibacterial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Microbial Antibacterial Drugs Sales by Region (2020-2025) & (Kilotons)
Table 18. Global Microbial Antibacterial Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Microbial Antibacterial Drugs Sales by Region (2026-2031) & (Kilotons)
Table 20. Global Microbial Antibacterial Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Microbial Antibacterial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Microbial Antibacterial Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Microbial Antibacterial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Microbial Antibacterial Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Microbial Antibacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Microbial Antibacterial Drugs Sales by Country (2020-2025) & (Kilotons)
Table 27. North America Microbial Antibacterial Drugs Sales by Country (2026-2031) & (Kilotons)
Table 28. North America Microbial Antibacterial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Microbial Antibacterial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Microbial Antibacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Microbial Antibacterial Drugs Sales by Country (2020-2025) & (Kilotons)
Table 32. Europe Microbial Antibacterial Drugs Sales by Country (2026-2031) & (Kilotons)
Table 33. Europe Microbial Antibacterial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Microbial Antibacterial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Microbial Antibacterial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Microbial Antibacterial Drugs Sales by Region (2020-2025) & (Kilotons)
Table 37. Asia Pacific Microbial Antibacterial Drugs Sales by Region (2026-2031) & (Kilotons)
Table 38. Asia Pacific Microbial Antibacterial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Microbial Antibacterial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Microbial Antibacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Microbial Antibacterial Drugs Sales by Country (2020-2025) & (Kilotons)
Table 42. Latin America Microbial Antibacterial Drugs Sales by Country (2026-2031) & (Kilotons)
Table 43. Latin America Microbial Antibacterial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Microbial Antibacterial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Microbial Antibacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Microbial Antibacterial Drugs Sales by Country (2020-2025) & (Kilotons)
Table 47. Middle East and Africa Microbial Antibacterial Drugs Sales by Country (2026-2031) & (Kilotons)
Table 48. Middle East and Africa Microbial Antibacterial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Microbial Antibacterial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Microbial Antibacterial Drugs Sales (Kilotons) by Type (2020-2025)
Table 51. Global Microbial Antibacterial Drugs Sales (Kilotons) by Type (2026-2031)
Table 52. Global Microbial Antibacterial Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Microbial Antibacterial Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Microbial Antibacterial Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Microbial Antibacterial Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Microbial Antibacterial Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Microbial Antibacterial Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Microbial Antibacterial Drugs Price (US$/Ton) by Type (2020-2025)
Table 59. Global Microbial Antibacterial Drugs Price (US$/Ton) by Type (2026-2031)
Table 60. Global Microbial Antibacterial Drugs Sales (Kilotons) by Application (2020-2025)
Table 61. Global Microbial Antibacterial Drugs Sales (Kilotons) by Application (2026-2031)
Table 62. Global Microbial Antibacterial Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Microbial Antibacterial Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Microbial Antibacterial Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Microbial Antibacterial Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Microbial Antibacterial Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Microbial Antibacterial Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Microbial Antibacterial Drugs Price (US$/Ton) by Application (2020-2025)
Table 69. Global Microbial Antibacterial Drugs Price (US$/Ton) by Application (2026-2031)
Table 70. Seres Therapeutics Company Information
Table 71. Seres Therapeutics Description and Business Overview
Table 72. Seres Therapeutics Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Seres Therapeutics Microbial Antibacterial Drugs Product
Table 74. Seres Therapeutics Recent Developments/Updates
Table 75. Assembly Biosciences Company Information
Table 76. Assembly Biosciences Description and Business Overview
Table 77. Assembly Biosciences Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Assembly Biosciences Microbial Antibacterial Drugs Product
Table 79. Assembly Biosciences Recent Developments/Updates
Table 80. Synthetic Biologics Company Information
Table 81. Synthetic Biologics Description and Business Overview
Table 82. Synthetic Biologics Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Synthetic Biologics Microbial Antibacterial Drugs Product
Table 84. Synthetic Biologics Recent Developments/Updates
Table 85. Interxon Company Information
Table 86. Interxon Description and Business Overview
Table 87. Interxon Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Interxon Microbial Antibacterial Drugs Product
Table 89. Interxon Recent Developments/Updates
Table 90. PureTech Company Information
Table 91. PureTech Description and Business Overview
Table 92. PureTech Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. PureTech Microbial Antibacterial Drugs Product
Table 94. PureTech Recent Developments/Updates
Table 95. Synlogic Company Information
Table 96. Synlogic Description and Business Overview
Table 97. Synlogic Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Synlogic Microbial Antibacterial Drugs Product
Table 99. Synlogic Recent Developments/Updates
Table 100. Enterome BioScience Company Information
Table 101. Enterome BioScience Description and Business Overview
Table 102. Enterome BioScience Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Enterome BioScience Microbial Antibacterial Drugs Product
Table 104. Enterome BioScience Recent Developments/Updates
Table 105. 4D Pharma Company Information
Table 106. 4D Pharma Description and Business Overview
Table 107. 4D Pharma Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. 4D Pharma Microbial Antibacterial Drugs Product
Table 109. 4D Pharma Recent Developments/Updates
Table 110. Second Genome Company Information
Table 111. Second Genome Description and Business Overview
Table 112. Second Genome Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Second Genome Microbial Antibacterial Drugs Product
Table 114. Second Genome Recent Developments/Updates
Table 115. AOBiome Company Information
Table 116. AOBiome Description and Business Overview
Table 117. AOBiome Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. AOBiome Microbial Antibacterial Drugs Product
Table 119. AOBiome Recent Developments/Updates
Table 120. Rebiotix Company Information
Table 121. Rebiotix Description and Business Overview
Table 122. Rebiotix Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Rebiotix Microbial Antibacterial Drugs Product
Table 124. Rebiotix Recent Developments/Updates
Table 125. Metabiomics Company Information
Table 126. Metabiomics Description and Business Overview
Table 127. Metabiomics Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Metabiomics Microbial Antibacterial Drugs Product
Table 129. Metabiomics Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Microbial Antibacterial Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Symberix Company Information
Table 136. Symberix Description and Business Overview
Table 137. Symberix Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Symberix Microbial Antibacterial Drugs Product
Table 139. Symberix Recent Developments/Updates
Table 140. OpenBiome Company Information
Table 141. OpenBiome Description and Business Overview
Table 142. OpenBiome Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. OpenBiome Microbial Antibacterial Drugs Product
Table 144. OpenBiome Recent Developments/Updates
Table 145. Azitra Company Information
Table 146. Azitra Description and Business Overview
Table 147. Azitra Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Azitra Microbial Antibacterial Drugs Product
Table 149. Azitra Recent Developments/Updates
Table 150. Osel Company Information
Table 151. Osel Description and Business Overview
Table 152. Osel Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Osel Microbial Antibacterial Drugs Product
Table 154. Osel Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Microbial Antibacterial Drugs Distributors List
Table 158. Microbial Antibacterial Drugs Customers List
Table 159. Microbial Antibacterial Drugs Market Trends
Table 160. Microbial Antibacterial Drugs Market Drivers
Table 161. Microbial Antibacterial Drugs Market Challenges
Table 162. Microbial Antibacterial Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Microbial Antibacterial Drugs
Figure 2. Global Microbial Antibacterial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Microbial Antibacterial Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Dosage Form Product Picture
Figure 5. Enteric Capsules Product Picture
Figure 6. Global Microbial Antibacterial Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Microbial Antibacterial Drugs Market Share by Application: 2024 & 2031
Figure 8. Gastrointestinal Disorders
Figure 9. Autoimmune Disorders
Figure 10. Diabetes
Figure 11. Cancer
Figure 12. Others
Figure 13. Global Microbial Antibacterial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Microbial Antibacterial Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Microbial Antibacterial Drugs Sales (2020-2031) & (Kilotons)
Figure 16. Global Microbial Antibacterial Drugs Average Price (US$/Ton) & (2020-2031)
Figure 17. Microbial Antibacterial Drugs Report Years Considered
Figure 18. Microbial Antibacterial Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Microbial Antibacterial Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Microbial Antibacterial Drugs Players: Market Share by Revenue in Microbial Antibacterial Drugs in 2024
Figure 21. Microbial Antibacterial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Microbial Antibacterial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Microbial Antibacterial Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Microbial Antibacterial Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Microbial Antibacterial Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Microbial Antibacterial Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Microbial Antibacterial Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Microbial Antibacterial Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Microbial Antibacterial Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Microbial Antibacterial Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Microbial Antibacterial Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Microbial Antibacterial Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Microbial Antibacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Microbial Antibacterial Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Microbial Antibacterial Drugs by Type (2020-2031)
Figure 55. Global Microbial Antibacterial Drugs Price (US$/Ton) by Type (2020-2031)
Figure 56. Global Sales Market Share of Microbial Antibacterial Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Microbial Antibacterial Drugs by Application (2020-2031)
Figure 58. Global Microbial Antibacterial Drugs Price (US$/Ton) by Application (2020-2031)
Figure 59. Microbial Antibacterial Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
